国：イギリス 取引所：IOB セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
バイオテクノロジー (25)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S 0QIU.IL | DKK 295.60 43.34 USD |
-1.07
|
DKK 1.24T 181.99B USD | DKK 0.00 0 USD | DKK 295.60 43.34 USD | DKK 295.60 43.34 USD | DKK 1.24T 181.99B USD | 19.89 | DKK 14.86 2.18 USD | |
| UCB SA 0NZT.IL | €225.90 246.94 USD |
+0.74
|
€45.96B 50.24B USD | €53.00 57.94 USD | €225.70 246.72 USD | €226.30 247.38 USD | €45.96B 50.24B USD | 132.88 | €1.70 1.86 USD | |
| argenx SE 0QW0.IL | €749.60 819.41 USD |
+1.56
|
€44.10B 48.21B USD | €3.00 3.28 USD | €748.40 818.1 USD | €749.60 819.41 USD | €44.10B 48.21B USD | 0 | -€6.55 -7.1 USD | |
| Moderna, Inc. 0A45.IL | $24.60 — |
+2.29
|
$11.96B — | $350.00 — | $24.50 — | $24.70 — | $11.96B — | 9.17 | $2.68 — | |
| Bavarian Nordic A/S 0DPB.IL | DKK 190.60 27.95 USD |
-17.22
|
DKK 17.89B 2.62B USD | DKK 0.00 0 USD | DKK 190.60 27.95 USD | DKK 190.60 27.95 USD | DKK 17.89B 2.62B USD | 13.52 | DKK 14.09 2.07 USD | |
| Galapagos NV 0JXZ.IL | €27.96 30.56 USD |
+1.19
|
€1.84B 2.01B USD | €3.00 3.28 USD | €27.94 30.54 USD | €27.96 30.56 USD | €1.84B 2.01B USD | 0 | -€2.44 -2.6 USD | |
| Pharming Group N.V. 0QCO.IL | €1.46 1.59 USD |
+0.14
|
€1.14B 1.25B USD | €196.00 214.25 USD | €1.46 1.59 USD | €1.46 1.59 USD | €1.14B 1.25B USD | 0 | -€0.02 -0.02 USD | |
| Idorsia Ltd 0RQE.IL | CHF 3.26 3.71 USD |
+4.58
|
CHF 827.72M 941.77M USD | CHF 920.72K 1.05M USD | CHF 3.26 3.71 USD | CHF 3.26 3.71 USD | CHF 827.72M 941.77M USD | 0 | -CHF 4.57 -5.1 USD | |
| DBV Technologies S.A. 0QAJ.IL | €2.44 2.67 USD |
+0.21
|
€276.76M 302.54M USD | €49.00 53.56 USD | €2.44 2.67 USD | €2.44 2.67 USD | €276.76M 302.54M USD | 0 | -€0.93 -1.01 USD | |
| Cellectis S.A. 0WA2.IL | €3.19 3.49 USD |
+1.35
|
€230.33M 251.78M USD | €0.00 0 USD | €3.19 3.49 USD | €3.19 3.49 USD | €230.33M 251.78M USD | 0 | -€1.42 -1.5 USD | |
| Genfit S.A. 0QT6.IL | €3.62 3.96 USD |
-0.06
|
€193.38M 211.39M USD | €0.00 0 USD | €3.62 3.96 USD | €3.62 3.96 USD | €193.38M 211.39M USD | 0 | -€0.67 -0.7 USD | |
| Innate Pharma S.A. 0EVI.IL | €1.80 1.97 USD |
-4.51
|
€144.97M 158.47M USD | €1.08K 1.18K USD | €1.77 1.93 USD | €1.90 2.08 USD | €144.97M 158.47M USD | 0 | -€0.78 -0.8 USD | |
| Poxel S.A. 0RA2.IL | €0.26 0.29 USD |
+0.38
|
€9.22M 10.08M USD | €346.39K 378.65K USD | €0.26 0.29 USD | €0.26 0.29 USD | €9.22M 10.08M USD | 0 | -€1.09 -1.1 USD | |
| BioNTech SE 0A3M.IL | $104.99 — |
+0.47
|
$28.88B — | $50.00 — | $104.99 — | $104.99 — | $28.88B — | 5.83 | $18.00 — | |
| Genmab A/S 0MGB.IL | DKK 1,873.50 274.69 USD |
-0.53
|
DKK 150.03B 22B USD | DKK 30.00 4.4 USD | DKK 1,873.50 274.69 USD | DKK 1,881.00 275.79 USD | DKK 150.03B 22B USD | 26.47 | DKK 70.77 10.38 USD | |
| ALK-Abelló A/S 0OIR.IL | DKK 203.20 29.79 USD |
+35.97
|
DKK 40.79B 5.98B USD | DKK 273.00 40.03 USD | DKK 202.40 29.68 USD | DKK 204.00 29.91 USD | DKK 40.79B 5.98B USD | 126.21 | DKK 1.61 0.24 USD | |
| Zealand Pharma A/S 0NZU.IL | DKK 441.40 64.72 USD |
+0.11
|
DKK 26.32B 3.86B USD | DKK 334.00 48.97 USD | DKK 441.40 64.72 USD | DKK 442.60 64.89 USD | DKK 26.32B 3.86B USD | 0 | -DKK 15.13 -2.2 USD | |
| BioArctic AB (publ) 0RV2.IL | SEK 270.82 26.43 USD |
+1.16
|
SEK 27.09B 2.64B USD | SEK 7.31K 713.35 USD | SEK 270.82 26.43 USD | SEK 270.82 26.43 USD | SEK 27.09B 2.64B USD | 88.21 | SEK 3.07 0.3 USD | |
| Pharma Mar, S.A. 0RC6.IL | €71.23 77.86 USD |
-0.77
|
€1.29B 1.41B USD | €116.00 126.8 USD | €71.23 77.86 USD | €71.23 77.86 USD | €1.29B 1.41B USD | 64.16 | €1.11 1.21 USD | |
| CureVac N.V. 0A9E.IL | $5.23 — |
-1.92
|
$1.31B — | $5.51K — | $5.23 — | $5.23 — | $1.31B — | 0 | -$1.50 — | |
| BioInvent International AB (publ) 0H22.IL | SEK 31.48 3.07 USD |
-0.63
|
SEK 2.21B 216.17M USD | SEK 199.00K 19.42K USD | SEK 31.48 3.07 USD | SEK 31.48 3.07 USD | SEK 2.21B 216.17M USD | 0 | -SEK 5.01 -0.4 USD | |
| Hansa Biopharma AB (publ) 0RC7.IL | SEK 27.13 2.65 USD |
+0.97
|
SEK 1.78B 174.23M USD | SEK 36.88K 3.6K USD | SEK 27.13 2.65 USD | SEK 27.13 2.65 USD | SEK 1.78B 174.23M USD | 0 | -SEK 16.03 -1.5 USD | |
| Thor Medical ASA 0R6Y.IL | NOK 3.62 0.35 USD |
-1.3
|
NOK 1.04B 99.42M USD | NOK 210.00K 20.14K USD | NOK 3.62 0.35 USD | NOK 3.62 0.35 USD | NOK 1.04B 99.42M USD | 0 | -NOK 1.17 -0.1 USD | |
| Oncopeptides AB (publ) 0RN4.IL | SEK 4.70 0.46 USD |
-3.89
|
SEK 482.02M 47.05M USD | SEK 478.00 46.66 USD | SEK 4.70 0.46 USD | SEK 4.82 0.47 USD | SEK 482.02M 47.05M USD | 0 | -SEK 3.39 -0.3 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}